A quick peek into the report
Table of Contents
1.1 Trends: Current and Future Impact Assessment
1.1.1 Sample Text
1.1.2 Trend 1
1.1.3 Trend 2
1.1.4 Trend 3
1.2 Supply Chain Overview
1.2.1 Value Chain Analysis
1.2.2 Market Map
1.3 Research and Development Review
1.3.1 Patent Filing Trend (by Country, Company)
1.4 Regulatory Landscape
1.5 Impact Analysis for Key Global Events- Covid19
1.6 Market Dynamics Overview
1.6.1 Market Drivers
1.6.2 Market Restraints
1.6.3 Market Opportunities
1.7 Reimbursement Scenario
2.1 Application Segmentation
2.2 Application Summary
2.3 Global Immunoassay Market (By Technology)
2.3.1 ELISA
2.3.2 Chemiluminiscence Immunoassay (CLIA)
2.3.3 Immunofluorescence Immunoassay
2.3.4 Rapid Tests
2.3.5 ELISpot
2.3.6 Western Blotting
2.3.7 Other Technologies
2.4 Global Immunoassay Market (by End User)
2.4.1 Hospitals
2.4.2 Academic & Research Centres
2.4.3 Pharmaceutical & Biotechnology Companies
2.4.4 Clinical Laboratories
2.4.5 Others
2.5 Global Immunoassay Market (by Disease Area Type)
2.5.1 Oncology
2.5.2 Endocrinology
2.5.3 Infectious Disease
2.5.4 Cardiology
2.5.5 Newborn Screening
2.5.6 Autoimmune Disorders
2.5.7 Toxicology
2.5.8 Other Applications
3.1 Product Segmentation
3.2 Product Summary
3.3 Global Immunoassay Market (by Product)
3.3.1 Reagents and Kits
3.3.1.1 ELISA Reagents and Kits
3.3.1.2 CLIA Reagents and Kits
3.3.1.3 IFA Reagents and Kits
3.3.1.4 Rapid Diagnostic Reagents and Kits
3.3.1.5 ELISpot Reagents and Kits
3.3.1.6 Western Blot Reagents and Kits
3.3.1.7 Other Reagents and Kits
3.3.2 Analyzers
4.1 Regional Summary
4.2 Drivers and Restraints as you go alone……
4.3 North America
4.3.1 Regional Overview
4.3.2 Driving Factors for Market Growth
4.3.3 Factors Challenging the Market
4.3.4 Application
4.3.5 Product
4.3.6 U.S.
4.3.7 U.S. Immunoassay Market by Application
4.3.8 U.S. Immunoassay Market by Product
4.3.9 Canada
4.3.10 Canada Immunoassay Market by Application
4.3.11 Canada Immunoassay Market by Product
4.4 Europe
4.4.1 Regional Overview
4.4.2 Driving Factors for Market Growth
4.4.3 Factors Challenging the Market
4.4.4 Application
4.4.5 Product
4.4.6 France
4.4.7 France Immunoassay Market by Application
4.4.8 France Immunoassay Market by Product
4.4.9 Germany
4.4.10 Germany Immunoassay Market by Application
4.4.11 Germany Immunoassay Market by Product
4.4.12 U.K.
4.4.13 U.K. Immunoassay Market by Application
4.4.14 U.K. Immunoassay Market by Product
4.4.15 Rest of Europe
4.4.16 Rest of Europe Immunoassay Market by Application
4.4.17 Rest of Europe Immunoassay Market by Product
4.5 Asia Pacific
4.5.1 Regional Overview
4.5.2 Driving Factors for Market Growth
4.5.3 Factors Challenging the Market
4.5.4 Application
4.5.5 Product
4.5.6 China
4.5.7 China Immunoassay Market by Application
4.5.8 China Immunoassay Market by Product
4.5.9 India
4.5.10 India Immunoassay Market by Application
4.5.11 India Immunoassay Market by Product
4.5.12 Japan
4.5.13 Japan Immunoassay Market by Application
4.5.14 Japan Immunoassay Market by Product
4.5.15 Rest-of-Asia-Pacific
4.5.16 Rest-of-Asia-Pacific Immunoassay Market by Application
4.5.17 Rest-of-Asia-Pacific Immunoassay Market by Product
4.6 Rest-of-the-World
4.6.1 Regional Overview
4.6.2 Driving Factors for Market Growth
4.6.3 Factors Challenging the Market
4.6.4 Application
4.6.5 Product
4.6.6 The Middle East and Africa
4.6.7 The Middle East and Africa Immunoassay Market by Application
4.6.8 The Middle East and Africa Immunoassay Market by Product
4.6.9 Latin America
4.6.10 Latin America Immunoassay Market by Application
4.6.11 Latin America Immunoassay Market by Product
5.1 Next Frontiers…..
5.2 Geographic Assessment
5.2.1 Abnova Corporation
5.2.1.1 Overview
5.2.1.2 Top Products / Product Portfolio
5.2.1.3 Top Competitors
5.2.1.4 Target Customers
5.2.1.5 Key Personnel
5.2.1.6 Analyst View
5.2.1.7 Market Share
5.2.2 Bio-Techne
5.2.2.1 Overview
5.2.2.2 Top Products / Product Portfolio
5.2.2.3 Top Competitors
5.2.2.4 Target Customers
5.2.2.5 Key Personnel
5.2.2.6 Analyst View
5.2.2.7 Market Share
5.2.3 Boster Biological Technology
5.2.3.1 Overview
5.2.3.2 Top Products / Product Portfolio
5.2.3.3 Top Competitors
5.2.3.4 Target Customers
5.2.3.5 Key Personnel
5.2.3.6 Analyst View
5.2.3.7 Market Share
5.2.4 Cell Sciences, Inc.
5.2.4.1 Overview
5.2.4.2 Top Products / Product Portfolio
5.2.4.3 Top Competitors
5.2.4.4 Target Customers
5.2.4.5 Key Personnel
5.2.4.6 Analyst View
5.2.4.7 Market Share
5.2.5 Cellabs
5.2.5.1 Overview
5.2.5.2 Top Products / Product Portfolio
5.2.5.3 Top Competitors
5.2.5.4 Target Customers
5.2.5.5 Key Personnel
5.2.5.6 Analyst View
5.2.5.7 Market Share
5.2.6 Creative Diagnostics
5.2.6.1 Overview
5.2.6.2 Top Products / Product Portfolio
5.2.6.3 Top Competitors
5.2.6.4 Target Customers
5.2.6.5 Key Personnel
5.2.6.6 Analyst View
5.2.6.7 Market Share
5.2.7 Elabscience Biotechnology Inc.
5.2.7.1 Overview
5.2.7.2 Top Products / Product Portfolio
5.2.7.3 Top Competitors
5.2.7.4 Target Customers
5.2.7.5 Key Personnel
5.2.7.6 Analyst View
5.2.7.7 Market Share
5.2.8 Enzo Biochem Inc.
5.2.8.1 Overview
5.2.8.2 Top Products / Product Portfolio
5.2.8.3 Top Competitors
5.2.8.4 Target Customers
5.2.8.5 Key Personnel
5.2.8.6 Analyst View
5.2.8.7 Market Share
5.2.9 Epitope Diagnostics, Inc.
5.2.9.1 Overview
5.2.9.2 Top Products / Product Portfolio
5.2.9.3 Top Competitors
5.2.9.4 Target Customers
5.2.9.5 Key Personnel
5.2.9.6 Analyst View
5.2.9.7 Market Share
5.2.10 Gyros Protein Technologies AB
5.2.10.1 Overview
5.2.10.2 Top Products / Product Portfolio
5.2.10.3 Top Competitors
5.2.10.4 Target Customers
5.2.10.5 Key Personnel
5.2.10.6 Analyst View
5.2.10.7 Market Share
5.2.11 InBios International, Inc. USA
5.2.11.1 Overview
5.2.11.2 Top Products / Product Portfolio
5.2.11.3 Top Competitors
5.2.11.4 Target Customers
5.2.11.5 Key Personnel
5.2.11.6 Analyst View
5.2.11.7 Market Share
5.2.12 J. Mitra & Co. Pvt. Ltd.
5.2.12.1 Overview
5.2.12.2 Top Products / Product Portfolio
5.2.12.3 Top Competitors
5.2.12.4 Target Customers
5.2.12.5 Key Personnel
5.2.12.6 Analyst View
5.2.12.7 Market Share
5.2.13 Kamiya Biomedical Company
5.2.13.1 Overview
5.2.13.2 Top Products / Product Portfolio
5.2.13.3 Top Competitors
5.2.13.4 Target Customers
5.2.13.5 Key Personnel
5.2.13.6 Analyst View
5.2.13.7 Market Share
5.2.14 Maccura Biotechnology Co., Ltd.
5.2.14.1 Overview
5.2.14.2 Top Products / Product Portfolio
5.2.14.3 Top Competitors
5.2.14.4 Target Customers
5.2.14.5 Key Personnel
5.2.14.6 Analyst View
5.2.14.7 Market Share
5.2.15 Merck KGaA
5.2.15.1 Overview
5.2.15.2 Top Products / Product Portfolio
5.2.15.3 Top Competitors
5.2.15.4 Target Customers
5.2.15.5 Key Personnel
5.2.15.6 Analyst View
5.2.15.7 Market Share
5.2.16 Meridian Bioscience
5.2.16.1 Overview
5.2.16.2 Top Products / Product Portfolio
5.2.16.3 Top Competitors
5.2.16.4 Target Customers
5.2.16.5 Key Personnel
5.2.16.6 Analyst View
5.2.16.7 Market Share
5.2.17 SeraCare
5.2.17.1 Overview
5.2.17.2 Top Products / Product Portfolio
5.2.17.3 Top Competitors
5.2.17.4 Target Customers
5.2.17.5 Key Personnel
5.2.17.6 Analyst View
5.2.17.7 Market Share
5.2.18 Provision Healthcare
5.2.18.1 Overview
5.2.18.2 Top Products / Product Portfolio
5.2.18.3 Top Competitors
5.2.18.4 Target Customers
5.2.18.5 Key Personnel
5.2.18.6 Analyst View
5.2.18.7 Market Share
5.2.19 Tosoh Bioscience
5.2.19.1 Overview
5.2.19.2 Top Products / Product Portfolio
5.2.19.3 Top Competitors
5.2.19.4 Target Customers
5.2.19.5 Key Personnel
5.2.19.6 Analyst View
5.2.19.7 Market Share
5.2.20 Trivitron Healthcare
5.2.20.1 Overview
5.2.20.2 Top Products / Product Portfolio
5.2.20.3 Top Competitors
5.2.20.4 Target Customers
5.2.20.5 Key Personnel
5.2.20.6 Analyst View
5.2.20.7 Market Share
5.2.21 WAK-Chemie Medical GmbH
5.2.21.1 Overview
5.2.21.2 Top Products / Product Portfolio
5.2.21.3 Top Competitors
5.2.21.4 Target Customers
5.2.21.5 Key Personnel
5.2.21.6 Analyst View
5.2.21.7 Market Share
6.1 Data Sources
6.1.1 Primary Data Sources
6.1.2 Secondary Data Sources
6.1.3 Data Triangulation
6.2 Market Estimation and Forecast
Table 1: Market Snapshot
Table 2: Global Immunoassay Market, Opportunity
Table 3: Immunoassay Market, By Region, ($Million), 2022-2033
Table 4: North America Immunoassay Market, By End User ($ Million), 2022-2033
Table 5: North America Immunoassay Market, By Disease Area Type ($ Million), 2022-2033
Table 6: North America Immunoassay Market, By Technology ($ Million), 2022-2033
Table 7: North America Immunoassay Market, By Product ($ million), 2022-2033
Table 8: U.S. Immunoassay Market, By End User ($ Million), 2022-2033
Table 9: U.S. Immunoassay Market, By Disease Area Type ($ Million), 2022-2033
Table 10: U.S. Immunoassay Market, By Product ($ Million), 2022-2033
Table 11: Canada Immunoassay Market, By End User ($ Million), 2022-2033
Table 12: Canada Immunoassay Market, By Disease Area ($ Million), 2022-2033
Table 13: Canada Immunoassay Market, By Product ($ Million), 2022-2033
Table 14: Europe Immunoassay Market, By End User ($ Million), 2022-2033
Table 15: Europe Immunoassay Market, By Disease Area ($ Million), 2022-2033
Table 16: Europe Immunoassay Market, By Technology ($ Million), 2022-2033
Table 17: Europe Immunoassay Market, By Product ($ Million), 2022-2033
Table 18: France Immunoassay Market, By End User ($ Million), 2022-2033
Table 19: France Immunoassay Market, By Disease Area ($ Million), 2022-2033
Table 20: France Immunoassay Market, By Product ($ Million), 2022-2033
Table 21: Germany Immunoassay Market, By End User ($ Million), 2022-2033
Table 22: Germany Immunoassay Market, By Disease Area ($ Million), 2022-2033
Table 23: Germany Immunoassay Market, By Product ($ Million), 2022-2033
Table 24: U.K. Immunoassay Market, By End User ($ Million), 2022-2033
Table 25: U.K. Immunoassay Market, By Disease Area ($ Million), 2022-2033
Table 26: U.K. Immunoassay Market, By Product ($ Million), 2022-2033
Table 27: Rest of Europe Immunoassay Market, By End User ($ Million), 2022-2033
Table 28: Rest of Europe Immunoassay Market, By Disease Area ($ Million), 2022-2033
Table 29: Rest of Europe Immunoassay Market, By Product ($ Million), 2022-2033
Table 30: Asia Pacific Immunoassay Market, By End User ($ Million), 2022-2033
Table 31: Asia Pacific Immunoassay Market, By Disease Area ($ Million), 2022-2033
Table 32: Asia Pacific Immunoassay Market, By Technology ($ Million), 2022-2033
Table 33: Asia Pacific Immunoassay Market, By Product ($ Million), 2022-2033
Table 34: China Immunoassay Market, By End User ($ Million), 2022-2033
Table 35: China Immunoassay Market, By Disease Area ($ Million), 2022-2033
Table 36: China Immunoassay Market, By Product ($ Million), 2022-2033
Table 37: India Immunoassay Market, By End User ($ Million), 2022-2033
Table 38: India Immunoassay Market, By Disease Area ($ Million), 2022-2033
Table 39: India Immunoassay Market, By Product ($ Million), 2022-2033
Table 40: Japan Immunoassay Market, By End User ($ Million), 2022-2033
Table 41: Japan Immunoassay Market, By Disease Area ($ Million), 2022-2033
Table 42: Japan Immunoassay Market, By Product ($ Million), 2022-2033
Table 43: Rest of Asia-Pacific Immunoassay Market, By End User ($ Million), 2022-2033
Table 44: Rest of Asia-Pacific Immunoassay Market, By Disease Area ($ Million), 2022-2033
Table 45: Rest of Asia-Pacific Immunoassay Market, By Product ($ Million), 2022-2033
Table 46: Rest-of-the-World Immunoassay Market, By End User ($ Million), 2022-2033
Table 47: Rest-of-the-World Immunoassay Market, By Disease Area ($ Million), 2022-2033
Table 48: Rest-of-the-World Immunoassay Market, By Technology ($ Million), 2022-2033
Table 49: Rest-of-the-World Immunoassay Market, By Product ($ Million), 2022-2033
Table 50: The Middle East and Africa Immunoassay Market, By End User ($ Million), 2022-2033
Table 51: The Middle East and Africa Immunoassay Market, By Disease Area ($ Million), 2022-2033
Table 52: The Middle East and Africa Immunoassay Market, By Product ($ Million), 2022-2033
Table 53: Latin America Immunoassay Market, By End User ($ Million), 2022-2033
Table 54: Latin America Immunoassay Market, By Disease Area ($ Million), 2022-2033
Table 55: Latin America Immunoassay Market, By Product ($ Million), 2022-2033
Table 56: Market Share
Figure 1: Region/country Largest Share of Market
Figure 2: Pricing/Cost Analysis by Region, Supply Chain
Figure 3: Global Immunoassay Market, by Disease Area Type, 2022, 2026, and 2033
Figure 4: Global Immunoassay Market, by Technology, 2022, 2026, and 2033
Figure 5: Global Immunoassay Market, by End User, 2022, 2026, and 2033
Figure 6: Global Immunoassay Market, by Products, 2022, 2026, and 2033
Figure 7: Key events to keep track of
Figure 8: Supply Chain and Identifying Risks within the Supply Chain
Figure 9: Global Immunoassay Market, by Country, January 2020-December 2023
Figure 10: Global Immunoassay Market, by Company, January 2020-December 2022
Figure 11: Impact Analysis of Market Navigating Factors
Figure 12: U.S. Immunoassay Market, By End User ($ Million), 2022-2033
Figure 13: U.S. Immunoassay Market, By Disease Area ($ Million), 2022-2033
Figure 14: U.S. Immunoassay Market, By Product ($ Million), 2022-2033
Figure 15: Canada Immunoassay Market, By End User ($ Million), 2022-2033
Figure 16: Canada Immunoassay Market, By Disease Area ($ Million), 2022-2033
Figure 17: Canada Immunoassay Market, By Product ($ Million), 2022-2033
Figure 18: France Immunoassay Market, By End User ($ Million), 2022-2033
Figure 19: France Immunoassay Market, By Disease Area ($ Million), 2022-2033
Figure 20: France Immunoassay Market, By Product ($ Million), 2022-2033
Figure 21: Germany Immunoassay Market, By End User ($ Million), 2022-2033
Figure 22: Germany Immunoassay Market, By Disease Area ($ Million), 2022-2033
Figure 23: Germany Immunoassay Market, By Product ($ Million), 2022-2033
Figure 24: U.K. Immunoassay Market, By End User ($ Million), 2022-2033
Figure 25: U.K. Immunoassay Market, By Disease Area ($ Million), 2022-2033
Figure 26: U.K. Immunoassay Market, By Product ($ Million), 2022-2033
Figure 27: Rest of Europe Immunoassay Market, By End User ($ Million), 2022-2033
Figure 28: Rest of Europe Immunoassay Market, By Disease Area ($ Million), 2022-2033
Figure 29: Rest of Europe Immunoassay Market, By Product ($ Million), 2022-2033
Figure 30: China Immunoassay Market, By End User ($ Million), 2022-2033
Figure 31: China Immunoassay Market, By Disease Area ($ Million), 2022-2033
Figure 32: China Immunoassay Market, By Product ($ Million), 2022-2033
Figure 33: India Immunoassay Market, By End User ($ Million), 2022-2033
Figure 34: India Immunoassay Market, By Disease Area ($ Million), 2022-2033
Figure 35: India Immunoassay Market, By Product ($ Million), 2022-2033
Figure 36: Japan Immunoassay Market, By End User ($ Million), 2022-2033
Figure 37: Japan Immunoassay Market, By Disease Area ($ Million), 2022-2033
Figure 38: Japan Immunoassay Market, By Product ($ Million), 2022-2033
Figure 39: Rest-of-Asia-Pacific Immunoassay Market, By End User ($ Million), 2022-2033
Figure 40: Rest-of-Asia-Pacific Immunoassay Market, By Disease Area ($ Million), 2022-2033
Figure 41: Rest-of-Asia-Pacific Immunoassay Market, By Product ($ Million), 2022-2033
Figure 42: The Middle East and Africa Immunoassay Market, By End User ($ Million), 2022-2033
Figure 43: The Middle East and Africa Immunoassay Market, By Disease Area ($ Million), 2022-2033
Figure 44: The Middle East and Africa Immunoassay Market, By Product ($ Million), 2022-2033
Figure 45: Latin America Immunoassay Market, By End User ($ Million), 2022-2033
Figure 46: Latin America Immunoassay Market, By Disease Area ($ Million), 2022-2033
Figure 47: Latin America Immunoassay Market, By Product ($ Million), 2022-2033
Figure 48: Strategic Initiatives, 2020 - 2023
Figure 49: Share of Strategic Initiatives
Figure 50: Data Triangulation
Figure 51: Top-Down and Bottom-Up Approach
Figure 52: Assumptions and Limitations
Global Immunoassay Market Report Coverage
|
Global Immunoassay Market? |
|||
|
Base Year |
2022 |
Market Size in 2022 |
$xx Billion |
|
Forecast Period |
2023-2033 |
Value Projection and Estimation by 2032 |
$xx Billion |
|
CAGR During Forecast Period |
xx |
Number of Pages |
|
|
Number of Tables |
|
Number of Figures |
|
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, product portfolio, and market penetration.
Some of the prominent names established in this market are:
- Abnova Corporation
- Bio-Techne
- Boster Biological Technology
- Cell Sciences, Inc
- Cellabs
- Creative Diagnostics
- Elabscience Biotechnology Inc
- Enzo Biochem Inc
- Epitope Diagnostics, Inc
- Gyros Protein Technologies AB
- SeraCare
- Provision Healthcare
- WAK-Chemie Medical GmbH
How can this report add value to an organization?
- This report aims to provide a comprehensive analysis of the immunoassay market, focusing on current trends, challenges and opportunities shaping the industry landscape.
- This report provides an in-depth analysis of the immunoassay market growth based on different segments in the market.
- This study also presents the competitive analysis, such as key strategies and capabilities of major players of the immunoassay market.
- This report presents a sound forecast estimates of the immunoassay market to help investors as well as industry players in taking informed decisions.
Introduction to Global Immunoassay Market
The immunoassay market has witnessed significant growth in recent years, driven by the rising incidence of infectious diseases, autoimmune disorders, increased awareness about preventive health measures and the growing demand for personalized medicine.
The immunoassay plays a pivotal role in diagnostics and therapeutic applications, encompassing a wide range of techniques such as ELISA, western blotting, radioimmunoassay, and rapid tests. As the global healthcare landscape evolves, immunoassays continue to be at the forefront of medical research and clinical diagnostics.
Post COVID-19 pandemic, the role of immunoassay increased significantly in disease diagnosis of infected asymptomatic and symptomatic individuals as well as in development of vaccines. A 'SelectScience' article published in January 2021 reported the application of vaccines as immunotherapies for conditions like certain cancers and Alzheimer's disease has spurred the advancement of sophisticated immunotherapies. This progress has, in turn, heightened the utilization of immunoassays in the evaluation of immunotherapies, thereby contributing to the expansion of the market.
Market Segmentation:
Segmentation 1: by Technology
- ELISA
- Chemiluminiscence Immunoassay (CLIA)
- Immunofluorescence Immunoassay
- Rapid Tests
- ELISpot
- Western Blotting
- Other Technologies
Segmentation 2: by End User
- Hospitals
- Academic & Research Centres
- Pharmaceutical & Biotechnology Companies
- Clinical Laboratories
- Others
Segmentation 3: by Product
- ELISA Reagents and Kits
- CLIA Reagents and Kits
- IFA Reagents and Kits
- Rapid Diagnostic Reagents and Kits
- ELISpot Reagents and Kits
- Western Blot Reagents and Kits
- Other Reagents and Kits
Segmentation 4: by Region
- North America
- Europe
- Asia-Pacific
Global Immunoassay Market
Focus on Products, End User, Disease Area, Therapy Type, System Type, and Over 16 Countries’ Data - Analysis and Forecast, 2023-2033